Where Will 22nd Century Group Inc (XXII) Stock Go Next After It Is Up 5.92% in a Week?

22nd Century Group Inc (XXII) stock has risen 5.92% over the past week and gets a Neutral rating from InvestorsObserver Sentiment Indicator.

22nd Century Group Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on XXII!

See Full XXII Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With XXII Stock Today?

22nd Century Group Inc (XXII) stock is up 7.19% while the S&P 500 is lower by -0.35% as of 3:47 PM on Tuesday, Aug 2. XXII is up $0.12 from the previous closing price of $1.67 on volume of 1,607,056 shares. Over the past year the S&P 500 has fallen -6.45% while XXII is lower by -43.71%. XXII lost -$0.23 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for 22nd Century Group Inc click here.

More About 22nd Century Group Inc

22nd Century Group Inc is a US-based plant biotechnology company. It focuses on developing technology that allows the increase or decrease in the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. The company is engaged in the research and development of potentially less harmful or modified risk tobacco products and novel tobacco plant varieties. Other business activities of the company include manufacture, marketing, sales, and distribution of SPECTRUM and VLN proprietary cigarettes, contract manufacturing of third-party branded tobacco products, research and development of plant varieties of hemp/cannabis, the sale of branded proprietary tobaccos, and among others. Click Here to get the full Stock Report for 22nd Century Group Inc stock.